In the press

James Carthew and Matthew Read on Saba and EWI in Investment Week

Biotech trusts top performance charts in February

James Carthew and Matthew Read comment on Saba’s EWI plan in Linus Uhlig’s article:

“We would expect to see a cash exit at asset value given that the supposedly independent new board has almost certainly already made up its mind to appoint Saba as manager, but that does not do anything for investors like me that actually want to be invested in global small cap growth.”

Matthew Read, senior analyst at QuotedData, noted that while Saba’s plan is “welcome”, his team “cannot get away from the fact that EWI shareholders have had multiple opportunities to express their views and, to date, have consistently backed the incumbent board and manager”.

Read the article here